Search

everythinglearnresearchcommunity

for

Search:↓

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Melatonin may help treat PCOS symptoms in rats.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Lipid nanoparticles can help deliver drugs through hair follicles but struggle to penetrate deeper skin layers.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Environmental factors can greatly reduce drug levels in hair.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

The new caffeine cream works better for hair growth than existing products.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Surfactants in shampoos and conditioners remove some but not all lipids from hair, and more research is needed to understand their full impact.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.